Robocath Overview

  • Founded
  • 2009
Founded
  • Status
  • Private
  • Employees
  • 46
Employees
  • Latest Deal Type
  • Series C
  • Latest Deal Amount
  • $43.5M
Latest Deal Amount
  • Investors
  • 15

Robocath General Information

Description

Developer of robotized medical devices designed for the treatment of vascular diseases. The company's robotics device, R-one, uses technology that optimizes the safety of robotic-assisted coronary angioplasty and incorporates a medical procedure which consists of revascularizing the cardiac muscle by inserting one or more implants (stents) into the arteries that supply it with blood, enabling surgeons and physicians to access reliable, precise assistance during procedures and enhance movements creating better interventional conditions, in particular by being totally protected from x-rays.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Primary Office
  • 2 rue Kellermann
  • 59100 Roubaix
  • France
+33 02 00 00 00 00

Robocath Timeline

2017201820192020
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Robocath Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series C) 29-Apr-2020 $43.5M 000.00 00000 Completed Generating Revenue
6. Later Stage VC 03-Sep-2019 00.000 000.00 Completed Generating Revenue
5. Later Stage VC 01-Mar-2018 00.000 000.00 000.00 Completed Generating Revenue
4. Accelerator/Incubator 07-Dec-2017 00.000 Completed Generating Revenue
3. Later Stage VC 01-May-2015 00000 00.000 00.000 Completed Generating Revenue
2. Early Stage VC 13-May-2013 $1.18M $1.18M 00.000 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Robocath’s complete valuation and funding history, request access »

Robocath Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
B 000,000 00.000000 000.00 000.00 00 000.00 00.000
A2 00,000 00.000000 000.00 000.00 00 000.00 00.00
A1 32,130 $1.234514 $34.57 $34.57 1x $34.57 12.62%
O 60,000 $1.234514
To view Robocath’s complete cap table history, request access »

Robocath Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of robotized medical devices designed for the treatment of vascular diseases. The company's robotics device, R
Therapeutic Devices
Roubaix, France
46 As of 2020
000.00
0000 0000-00-00
00000000000 000.00

00000000

ommodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fu
00000 0000000 000 00000000
South Jordan, UT
000 0000-00-00
000000&0

00000000

fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia des
00000000 0000000
Marlborough, MA
00 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Robocath Competitors (20)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vascular Insights Corporate Backed or Acquired South Jordan, UT 000000&0
00000000000 Venture Capital-Backed Marlborough, MA 00 00000 000000 - 000 00000
00000 0000000 Formerly VC-backed Campbell, CA 00 000.00 000000&0 000.00
0000000000 Formerly VC-backed Irvine, CA 00 000.00 000000&0 000.00
0000000 Venture Capital-Backed Burnaby, Canada 00 00.000 00000000000 00.000
You’re viewing 5 of 20 competitors. Get the full list »

Robocath Executive Team (5)

Name Title Board Seat Contact Info
Lucien Goffart Chief Executive Officer
Dominique Destriez Ph.D Chief Financial Officer
Bruno Fournier Ph.D Chief Technology Officer
Philippe Bencteux MD Founder, President & Chairman
To view Robocath’s complete executive team members history, request access »

Robocath Board Members (3)

Name Representing Role Since
Bruno Guicheux Ph.D GO Capital (France) Member, Strategic Committee 000 0000
Jean-Marc Buchet NCI Gestion Member, Strategic Committee 000 0000
Philippe Bencteux MD Robocath Founder, President & Chairman 000 0000
To view Robocath’s complete board members history, request access »

Robocath Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Robocath Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
ANAXAGO Real Estate Minority 000 0000 000000 0
CLIIF Other Minority 000 0000 000000 0
CS Group (France) Other Minority 000 0000 000000 0
MicroPort Scientific Corporation Minority 000 0000 000000 0
Silk Road Fund Company Sovereign Wealth Fund Minority 000 0000 000000 0
You’re viewing 5 of 15 investors. Get the full list »